In the brain, Hebbian-type and homeostatic forms of plasticity are affected by neuromodulators like dopamine (DA). Modifications of the perisynaptic extracellular matrix (ECM), controlling functions and mobility of synaptic receptors as well as diffusion of transmitters and neuromodulators in the extracellular space, are crucial for the manifestation of plasticity. Mechanistic links between synaptic activation and ECM modifications are largely unknown. Here, we report that neuromodulation via D1type DA receptors can induce targeted ECM proteolysis specifically at excitatory synapses of rat cortical neurons via proteases ADAMTS-4 and -5. We show that receptor activation induces increased proteolysis of brevican (BC) and aggrecan, two major constituents of the adult ECM, in vivo and in vitro. ADAMTS immunoreactivity is detected near synapses, and shRNA-mediated knockdown reduced BC cleavage. We outline a molecular scenario how synaptic activity and neuromodulation are linked to ECM rearrangements via increased cAMP levels, NMDA receptor activation, and intracellular calcium signaling.
Introduction
Synaptic transmission and plasticity are affected by perisynaptic and extrasynaptic factors including neuromodulators, glial-derived components or the extracellular matrix (ECM). The neuromodulator dopamine (DA) plays an important role in classical as well as newly discovered forms of synaptic plasticity, like neo-Hebbian or spike-timing-dependent plasticity (STDP), and hence is fundamental for various forms of learning (Tritsch and Sabatini, 2012; Lisman, 2017) . Dopaminergic modulation of synapses lasts from milliseconds to hours and comprises such diverse mechanisms as regulation of presynaptic neurotransmitter release, e.g. via control of axon terminal excitability or calcium influx, postsynaptic neurotransmitter detection via regulated receptor insertion, or synaptic integration in networks [summarized in (Tritsch and Sabatini, 2012) ]. Ultimately, dopaminergic activation also contributes to structural spine plasticity (Cannizzaro et al., 2019) .
Dopaminergic signaling is mediated through five different G protein-coupled receptors which can be attributed to two major subgroups: D1-like and D2-like DA receptors (Seeman, 1987; Tiberi et al., 1991; Dolan et al., 1995) . Both receptor subgroups have been shown to be coupled to adenylyl cyclase (AC). D1-like receptor activity leads to increased cAMP levels and activation of protein kinase A (PKA) [reviewed in (Beaulieu and Gainetdinov, 2011) ]. D1 receptors (D1Rs) are localized both pre-and postsynaptically (Miklosi et al., 2018) . D2 (D2R) and D3 receptors have also been found to be expressed both postsynaptically on DA target cells and presynaptically on dopaminergic neurons, respectively (Langer, 1997; Miklosi et al., 2018) .
DA receptors may interact heterologously with other receptor types, such as AMPA-type (AMPARs) and NMDA-type glutamate receptors (NMDARs). This association seems to be important in regulating long-term potentiation (LTP) and working memory ( Here, we follow the hypothesis that dopaminergic signaling can also affect the integrity of the hyaluronan (HA)-based extracellular matrix (ECM) surrounding and stabilizing synapses.
This type of ECM structures occurs in the brain as highly condensed perineuronal nets (PNNs) or the more diffuse perisynaptic ECM . The perisynaptic ECM constitutes a meshwork of macromolecules based on HA as a backbone for chondroitin sulfate proteoglycans like brevican (BC), aggrecan (ACAN), versican or neurocan, glycoproteins and link proteins [for review see (Celio et al., 1998; Sonntag et al., 2015) ]. As shown by us and others, in vivo-like ECM structures also develop in dissociated neuronal primary cultures (Miyata et al., 2005; John et al., 2006; Frischknecht et al., 2009; Faissner et al., 2010) .
Interestingly, the HA-based neural ECM is formed and remodeled in an activity-and plasticity-dependent manner under in vivo and in vitro conditions (Dityatev et al., 2007; Valenzuela et al., 2014) . Prime candidates for this remodeling are matrix metalloproteases (MMPs) and a disintegrin and metalloprotease with thrombospondin motifs (ADAMTS) enzymes (Rauch, 2004) . ADAMTS-4 was identified as one of the major proteases processing the proteoglycans ACAN, BC, neurocan and versican [reviewed in (Kelwick et al., 2015) ], thus being a key candidate for ECM remodeling in the brain (Zimmermann and Dours-Zimmermann, 2008; Gundelfinger et al., 2010) . ADAMTS enzymes can intrinsically be inhibited by tissue inhibitors of matrix proteases (TIMPs) and activated in response to central nervous system (CNS) injury or disease. However, the molecular pathways mediating neuronal activity-related control of ADAMTS remained elusive (Murphy, 2011; Gottschall and Howell, 2015) .
The extracellular activity of the tissue plasminogen activator (tPA) protease was shown to be significantly increased in the nucleus accumbens (NAc) of mice after activation of D1-like DA receptors via a PKA-dependent pathway (Ito et al., 2007) . This enhanced activity is probably associated with an increased release of tPA from vesicles into the extracellular space upon neuronal stimulation, what in turn regulates homeostatic and Hebbian-type synaptic plasticity (Bruno and Cuello, 2006; Ito et al., 2007; Jeanneret and Yepes, 2017) .
Here, we hypothesize that proteases modifying the HA-based perisynaptic ECM (i.e. ADAMTS-4 and -5) may also be released or activated after stimulation of D1-like DA receptors. Consequently, we investigated whether activation of DA receptors affects perisynaptic ECM integrity via stimulating release or activation of ECM-modifying ADAMTS proteases. We found DA receptor agonists increasing cleavage of the ECM constituents BC and ACAN in the rat cortex and in primary cortical cultures, identified the responsible matrix metalloproteases and unraveled the underlying intracellular signaling mechanisms.
Material and Methods

Antibodies and drugs
The following primary antibodies were used: rabbit anti-ADAMTS-4 (Abcam, Cambridge, UK), rabbit anti-ADAMTS-5 (OriGene, Rockland, MD, USA), rabbit anti-aggrecan (Merck Millipore, Burlington, MA, USA), rabbit anti-aggrecan neoepitope (Novus Biologicals, Centennial, CO, USA), guinea pig anti-brevican (Seidenbecher et al., 1995 Drugs were used in the given concentrations and obtained from the following companies: SKF38393 hydrobromide (for in vivo application 5 mg/kg body weight, Tocris Bioscience, Bristol, UK), SKF81297 hydrobromide (for in vitro application 1 µM, Tocris Bioscience), (-)- 
Primary neuronal cultures
Primary cultures of rat frontal cortical neurons were prepared for immunocytochemistry (ICC) and biochemistry as described previously (Lazarevic et al., 2011) . In brief, cells were plated on poly-D-lysine-coated glass coverslips in a density of 50,000 cells per coverslip (Ø 15 mm) for ICC and in a density of 500,000 cells per poly-D-lysine-coated well (Ø 35 mm) for biochemical analysis. Cultures were kept in an incubator at 37°C and 5% CO 2 for 21days in vitro (DIV).
Immunocytochemistry
After drug treatment living neurons were incubated with antibodies against full-length and cleaved BC (Rb399) in culture medium for 20 min at 37 °C and afterwards fixed with 4 % paraformaldehyde (PFA) in phosphate-buffered saline (PBS) for 5 min at room temperature (RT). Permeabilization and blocking were done by 30 min incubation with blocking solution (10 % fetal calf serum (FCS) in PBS, 0.1 % glycine, 0.1 % Triton-X 100) at RT. Cells were incubated with primary antibodies diluted in blocking solution overnight at 4 °C. On the following day cells were washed three times with PBS for 10 min, stained with fluorescently labeled secondary antibodies for 45 min at RT in the dark, washed three times with PBS for 10 min and mounted with Mowiol (Carl Roth, Karlsruhe, Germany). Preparations were kept at 4 °C until image acquisition. Images were acquired on a Zeiss Axioplan fluorescence microscope (Carl Zeiss, Oberkochen, Germany) and further processed for quantitative analysis with NHI ImageJ 1.51w (US National Institutes of Health, Bethesda, MD, USA).
Quantification of perisynaptic full-length BC and Rb399 intensities was done using
OpenView Software (OpenView 1.5, Noam Ziv) (described in (Friedman et al., 2000; Shapira et al., 2003) ). 
Design of shRNA plasmids
To knockdown rat ADAMTS-4 (GeneID: 66015) and ADAMTS-5 (GeneID: 304135) shRNA plasmids were cloned by the insertion of the siRNA sequences (Dharmacon, Lafayette, CO, USA; Horizon Discovery, Waterbeach, UK) targeting the open reading frame of rat ADAMTS-4 and ADAMTS-5 into AAV U6 GFP (Cell Biolabs Inc., San Diego, CA, USA) using BamH1 (New England Biolabs, Frankfurt a.M., Germany) and EcoR1 (New England Biolabs) restriction sites.
Generation of Adeno-associated viral particles
Positive clones were sequenced and used for the production of recombinant adeno-associated particles as described previously in (McClure et al., 2011) . In brief, HEK 293T cells were transfected using calcium phosphate with an equimolar mixture of the shRNA-encoding AAV U6 GFP, pHelper (Cell Biolabs Inc.) and RapCap DJ plasmids (Cell Biolabs Inc.). 48 h after transfection, cells were lysed using freeze-thaw cycles and treated with benzonase (50 U/ml; Merck Millipore) for 1 h at 37 °C. Lysates were centrifuged at 8,000 x g at 4 °C. Afterwards, supernatants were collected and filtered using a 0.2 micron filter. Filtrates were passed through pre-equilibrated HiTrap Heparin HP affinity columns (GE HealthCare, Chicago, IL, 
Knockdown of ECM-modifying proteases using shRNA
At DIV14 dissociated rat cortical cultures were infected either with shADAMTS-4, shADAMTS-5, or a scramble construct (2.07 * 10 7 particles/µl). One week later, infected cells (DIV 21) were treated with SKF81297 for 15 min to stimulate D1-like DA receptors.
Afterwards staining was performed as described above. However, cells were only stained for Rb399 and the synaptic marker Homer 1. Analysis and quantification were performed as indicated above. Knockdown efficiency was verified using biochemical analysis and immunocytochemical staining for either ADAMTS-4 or ADAMTS-5.
Optogenetic modulation of cAMP in dissociated cortical neurons
To stimulate cAMP levels in dissociated rat cortical neurons, cells (DIV 14) were infected with AAV2/7.Syn-bPAC-2A-tdimer. A 500-ms flash of a 455 nm LED (0.9 mW/mm 2 ) was applied to infected cultures at DIV 21. Cells were stained for the synaptic marker Homer 1 and Rb399 at different time points. BC cleavage was analyzed at Homer 1-positive synapses as described above.
Cell lysis
For cell lysis, culture medium was aspirated and cells were washed twice with ice-cold PBS.
Afterwards cells were incubated with lysis buffer (150 mM NaCl, 50 mM Tris/HCl, pH 8, 1%
Triton-X 100) containing a protease inhibitor cocktail (Complete ULTRA Tablets, EDTAfree, EASYpack, Roche Diagnostics, Basel, Schweiz) for 5 min on ice. Cells were scraped off, centrifuged at 10,000 x g at 4 °C for 15 min and supernatants were prepared for SDS-PAGE.
In vivo pharmacology and subcellular brain fractionation
Adult male Wistar rats were either injected with SKF38393 (5 mg/kg body weight, i.p.) or vehicle as described previously (Schicknick et al., 2008) . Rats were anesthetized with isoflurane 1h after injection followed by decapitation with a guillotine. For further use the prefrontal cortex (PFC), hippocampus and rest of the brain were dissected and stored at -80 °C as described in detail elsewhere (Niekisch et al., 2019) . Subcellular brain fractionation was performed according to (Seidenbecher et al., 1995) . Synaptosomal fractions were harvested and incubated with Chondroitinase ABC (Sigma-Aldrich) at 37 °C for 30 min.
SDS-PAGE and Western Blot
Samples were prepared for SDS-PAGE by adding 5x SDS loading buffer (250 mM Tris/HCl, pH 8, 50% Glycerol, 10% SDS, 0.25% bromphenol blue, 0.5 M DTT) and heating at 95°C for 10 minutes. 5-20 % Tris-glycine SDS polyacrylamide gels were run under reducing conditions. Transfer onto PVDF membranes (Merck Millipore) was performed according to standard protocols. Membranes were blocked with 5 % non-fat milk powder in TBS-T (150 mM sodium chloride, 50 mM Tris, 0.1 % (v/v) Tween20, pH 7.6) for 30 min at RT and immunodeveloped by overnight incubation at 4 °C with primary antibodies. After washing three times with TBS-T for 10 min, membranes were incubated with secondary antibodies for 60 min at RT and washed again three times with TBS-T for 10 min. Immunodetection was performed using an ECL Chemocam Imager (INTAS Science Imaging Instruments GmbH, Göttingen, Germany). Protein quantification was performed with NHI ImageJ 1.51w.
Statistical analysis
All statistical analyses and graphical representations were performed using GraphPad Prism 5 
Results
Increased BC cleavage in synaptosomes after D1-like DA receptor activation in vivo
It has been shown previously that the performance of Mongolian gerbils in an auditory learning task is modulated via DA, as the D1/D5 DA receptor agonist SKF38393 injected systemically shortly before, shortly after or 1 day before conditioning improved learning significantly (Schicknick et al., 2008) . In mice performing a similar task, we found changes in the expression levels of BC in the auditory cortex (Niekisch et al., 2019) . To test if DA may be involved in changed cortical BC levels, we pharmacologically activated DA D1-like receptors using systemic application of the D1/D5 agonist SKF38393 (5 mg/kg body weight, i.p.) in rats and investigated alterations in the ECM of the PFC where D1Rs are highly expressed [reviewed in (Beaulieu and Gainetdinov, 2011) ]. In addition to BC, we also included ACAN into our investigations, since this lectican is also present at perisynaptic sites (Lendvai et al., 2013) , and it is expressed in the cortex, where it was shown to act as a gatekeeper for physiological plasticity (Rowlands et al., 2018) . We analyzed total BC and ACAN expression levels in the homogenate and synaptosomal fractions of the PFC. For detection of proteolytically cleaved BC, we used a specific antibody against the newly emerged C-terminus (neo-epitope; Rb399) after cleavage by ADAMTS-4 or ADAMTS-5 (Nakamura et al., 2000; Hamel et al., 2005) . This antibody only detects ADAMTS-4/5cleaved fragments, but not full-length BC (Valenzuela et al., 2014) . We found that the amount of full-length BC, as well as the amount of cleaved BC, is unaltered in the homogenate fraction of control and SKF38393-treated animals ( Figure 1A , D, E). In the synaptosomal fraction there was a trend for reduction in the level of full-length BC by ~32 % (Figure 1A Representitive Western blots for the expression of cleaved BC using the neo-epitope antibody Rb399 in the homogenate (left) and the synaptosomal fraction (right). PSD95 served as an indicator for efficient fractionation. C) Representitive Western blots for the expression of aggrecan and the cleaved fragment at a size of 60 kDa in the homogenate (left) and the synaptosomal fraction (right). PSD95 served as an indicator for efficient fractionation. D) The levels of full-length BC are unalterd in the homogenate in control as well as in SKF-injected rats. In the synaptosomal fraction full-length BC is reduced after SKF38393 injection (homogenate: Ctl, 1 ± 0.1157, n = 4; SKF38, 1.056 ± 0.2574, n = 4; average ± SEM; Unpaired t test; P = 0.8491; synaptosomes: Ctl, 1 ± 0.1745, n = 4; SKF38, 0.5980 ± 0.0961, n = 4; average ± SEM; Unpaired t test; P = 0.0901) (nI FL BC = normalized intensity of full-length brevican). E) The expression of cleaved BC is unalterd in the homogenate after D1-like DA receptor activation, while in the synaptosomal fraction the levels of cleaved BC are significantly increased after SKF38393 treatment (homogenate: Ctl, 1 ± 0.0696, n = 4; SKF38, 0.8875 ± 0.116, n = 4; average ± SEM; Unpaired t test; P = 0.4373; synaptosomes: Ctl, 1 ± 0.12, n = 4; SKF38, 1.481 ± 0.1221, n = 4; average ± SEM; Unpaired t test; * P = 0.0308) (nI cl. BC = normalized intensity of cleaved brevican). F) The expression of cleaved BC as measured by the antibody Rb399 is unaltered in the homogenate but significantly increased in the synaptosomal fraction of SKF38393-injected rats (homogenate: Ctl, 1 ± 0.1301, n = 4; SKF38, 1.092 ± 0.1098, n = 4; average ± SEM; Unpaired t test; P = 0.8014; synaptosomes: Ctl, 1 ± 0.0826, n = 4; SKF38, 1.491 ± 0.1563, n = 4; average ± SEM; Unpaired t test; * P = 0.032) (nI cl. BC = normalized intensity of cleaved brevican). G) Fulllength ACAN is unaltered in the homogenate, while it is slightly but not significant decreased in the synaptosomal fraction after D1-like DA receptor activation (homogenate: Ctl, 1 ± 0.1176, n = 4; SKF38, 1.05 ± 0.1511, n = 4; average ± SEM; Unpaired t test; P = 0.8014; synaptosomes: Ctl, 1 ± 0.2342, n = 4; SKF38, 0.5798 ± 0.1598, n = 4; average ± SEM; Unpaired t test; P = 0.1889) (nI FL Aggr = normalized intensity of full-length aggrecan). H) The expression of cleaved ACAN is unalterd in the homogenate, while in the synaptosomal fraction the levels are significantly increased after D1-like DA receptor activation (homogenate: Ctl, 1 ± 0.0815, n = 4; SKF38, 1.044 ± 0.1017, n = 4; average ± SEM; Unpaired t test; P = 0.7458; synaptosomes: Ctl, 1 ± 0.1985, n = 4; SKF38, 1.7 ± 0.1317, n = 4; average ± SEM; Unpaired t test; * P = 0.0261) (nI cl. Aggr = normalized intensity of cleaved aggrecan).
D1 DA receptors are prominently expressed in rat dissociated cortical cultures
To investigate the underlying molecular mechanism of DA-regulated ECM tailoring, we used dissociated rat cortical primary neurons which express a mature type of ECM (John et al., 2006 ). First, we tested which types of DA receptors are expressed in the cultured neurons. For D2R, expression in rat dissociated cortical cultures has been reported previously (Sun et al., 2005) . To recapitulate this finding and to prove the expression of D1R in our culture system, we performed immunocytochemical stainings at DIV 21. Indeed, both types of DA receptors appeared as little puncta along dendrites and in the vicinity of Homer 1-positive excitatory synapses (Figure 2A Since, we observed an increase in ACAN cleavage in synaptosomes upon D1R stimulation in vivo ( Figure 1C , H), we tested whether this also happens in the culture system. Indeed, after D1-like DA receptor stimulation the amount of perisynaptically cleaved ACAN was doubled in comparison to control conditions. Similar to BC, D2-like DA receptor activation had no effect on ACAN cleavage at Homer-positive synapses, and the amount of perisynaptic total ACAN was unaltered in both conditions ( Figure 3G , H). Based on these findings we assume that DA signaling via D1-type receptors has the potential to restructure the perisynaptic ECM at excitatory synapses while D2-like receptor activation did not induce cleavage in the HAbased ECM.
Figure 3: Modification of perisynaptic ECM at excitatory synapses is D1-like DA receptor-dependent
A,C,E) Rat dissociated cortical neurons (DIV21) were either non-treated (Ctl) or treated with SKF81297 (SKF) or quinpirole (Quin) and stained for the excitatory synaptic marker Homer 1 (A, green), the inhibitory synaptic marker GAD65 (C, green) or the somato-dendritic marker MAP2 (E, green) and extracellular cleaved BC Rb399 (magenta) (scale bar: 5 µm). B) At Homer 1-positive excitatory synapses the amount of cleaved BC is significantly increased after D1-like, but not after D2-like DA receptor activation (tot.BC: Ctl, 1 ± 0.1742, n = 7; SKF, 1.045 ± 0.1745, n = 6; Quin, 0.9502 ± 0.2380, n = 7; average ± SEM; One-way ANOVA; P = 0.9471; cl. BC: Ctl, 1 ± 0.1673, n = 5; SKF, 1.864 ± 0.21, n = 7; Quin, 1.054 ± 0.1403, n = 5; average ± SEM; One-way ANOVA; P = 0.007; Dunnett's Multiple Comparison Test; * P<0.05). D,F) The amount of cleaved BC remained unaltered at inhibitory synapses (D) and on dendrites (F) after DA receptor activation ((D): Ctl, 1 ± 0.149, n = 9; SKF, 0.8521 ± 0.1359, n = 9; Quin, 0.8077 ± 0.0715, n = 9; average ± SEM; One-way ANOVA; P = 0.5239; (E): Ctl, 1 ± 0.1511, n = 8; SKF, 1.09 ± 0.1542, n = 8; Quin, 1.139 ± 0.1514, n = 8; average ± SEM; One-way ANOVA; P = 0.809). G) Rat dissociated cortical neurons (DIV21) were either non-treated (Ctl) or treated with SKF or Quin and stained for the excitatory synaptic marker Homer 1 (green) and extracellular cleaved ACAN (cl. ACAN) (magenta) (scale bar: 5 µm). H) ACAN cleavage was also increased at Homer 1-positive excitatory synapses after D1-like, but not D2like DA receptor activation. The amount of total ACAN was unaltered (tot. ACAN: Ctl, 1 ± 0.1055, n = 5; SKF, 0.7565 ± 0.0728, n = 6; Quin, 0.7995 ± 0.0728, n = 6; average ± SEM; One-way ANOVA; P = 0.2938; cl. ACAN: Ctl, 1 ± 0.1859, n = 5; SKF, 2.105 ± 0.2179, n = 5; Quin, 1.108 ± 0.291, n = 7; average ± SEM; One-way ANOVA; P = 0.0204; Dunnett's Multiple Comparison Test; * P<0.05). (nFI tot. BC = normalized fluorescent intensity of total brevican; nFI cl. BC = normalized fluorescent intensity of cleaved brevican; nFI tot. ACAN = normalized fluorescent intensity of total aggrecan; nFI cl. ACAN= normalized fluorescent intensity of cleaved aggrecan)
To prove that the augmented BC cleavage was due to activation of D1-like DA receptors, we applied the selective D1-like antagonist SCH23390 (SCH), which counteracted the SKF81297 effect at excitatory synapses ( Figure 4A ). The amount of cleaved BC was unaltered at inhibitory synapses and along whole dendrites after D1-like DA receptor inhibition ( Figure  4B , C). Thus, perisynaptic BC cleavage at excitatory synapses, indeed, proved to be D1-like DA receptor-dependent. . Therefore, we hypothesized these ECM-modifying proteases to be activated upon D1-like DA receptor stimulation. To test this, we blocked ADAMTS-4 and -5 using TIMP3, an efficient endogenous polypeptide inhibitor of these proteases. Indeed, treatment of cultures with TIMP3 alone or with TIMP3 20 min prior to D1-like receptor activation abolished the effect on BC cleavage ( Figure 5A ).
ADAMTS-4 and ADAMTS-5 are essential for SKF81297-induced BC cleavage
As TIMP3 inhibits both proteases, we used a knockdown approach to differentiate between their effects. We used recombinantly produced AAVs expressing small interfering RNAs to specifically knockdown either ADAMTS-4 or -5 in our culture system. First, we tested knockdown efficiency and specificity of two different shRNA constructs for each protease using immunocytochemical stainings and Western blot analysis (data not shown). The shRNA constructs shADAMTS-4.2 (shA4) and shADAMTS-5.2 (shA5) showed the most efficient knockdown of the respective protease in neurons (Supplementary Figure S2) . These constructs were used for further experiments. Next, rat dissociated cortical cultures (DIV 14) were infected with the above described shRNA constructs shA4 and shA5. At DIV 21 infected cells were treated with SKF81297 as described above and stained for Homer 1 and Rb399. As a negative control, cells were infected with AAV expressing scramble shRNA (Scr). Treatment with shRNAs shA4 and shA5 led to a strong decrease of cleaved BC under unstimulated conditions and prevented the SKF81297-induced increase in BC cleavage around excitatory synapses ( Figure 5B ). The concurrent knockdown of ADAMTS-4 and -5 revealed the same results as single knockdowns ( Figure 5B ), potentially because remaining cleaved BC is not acutely processed but stays bound at synapses. These results indicate that ECM-modifying proteases ADAMTS-4 and -5 are active under basal conditions and become more activated after D1-like DA receptor stimulation being essential for DA-dependent perisynaptic BC cleavage. To address the question, whether D1-like DA receptor activation is sufficient to induce increased perisynaptic ECM cleavage, we studied the role of general neuronal activity in this process. By blocking voltage-gated sodium channels using TTX to prevent action potentials and thus network activity the effect of the D1-like DA receptor agonist on BC cleavage was suppressed ( Figure 6A ). This suggests that neuronal activity is crucial for DA-mediated BC cleavage.
Since we found changes in cleaved BC particularly around excitatory synapses, where NMDARs are located and these receptors have been shown to interact functionally with D1like DA receptors (Haddad, 2005 Silencing neuronal networks with TTX results in an unaltered BC cleavage (Ctl, 1 ± 0.1599, n = 8; SKF, 1.632 ± 0.2036, n = 6; TTX, 1.039 ± 0.1211, n = 9; SKF+TTX, 0.9663 ± 0.1061, n = 9; average ± SEM; One-way ANOVA; P=0.0168; Dunnetti's Multiple Comparison Test; * P<0.05). B) Inhibition of all types of NMDARs with AP-5 abolishes SKF81297-induced perisynaptic BC cleavage (Ctl, 1 ± 0.105, n = 9; SKF, 1.376 ± 0.0671, n = 7; AP-5, 0.9599 ± 0.1183, n = 9; SKF+AP-5, 0.8976 ± 0.0964, n = 7; average ± SEM; One-way ANOVA; P = 0.0187; Dunnett's Multiple Comparison Test; * P<0.05). C) Especially, inhibition of NR2B-containing NMDARs with Ifenprodil (Ifen) results in unaltered BC cleavage (Ctl, 1 ± 0.107, n = 6; SKF, 1.392 ± 0.046, n = 9; Ifen, 1.039 ± 0.1436, n = 9; SKF+Ifen, 0.984 ± 0.0782, n = 8; average ± SEM; One-way ANOVA; P = 0.0199; Dunnett's Multiple Comparison Test; * P<0.05). D) SKF81297-induced perisynaptic BC cleavage depends on signaling via L-type VGCC (Ctl, 1 ± 0.1223, n = 8; SKF, 1.478 ± 0.0542, n = 7; Dilt, 0.9228 ± 0.1698, n = 7; Dilt + SKF, 0.7188 ± 0.1541, n = 5; average ± SEM; One-way ANOVA; P = 0.0046; Dunnett's Multiple Comparison Test; ** P<0.01). (nFI cl. BC = normalized fluorescent intensity of cleaved brevican)
Elevated intracellular cAMP levels entail enhanced BC cleavage
D1-like DA receptors are typically coupled to Gα s/olf and cause increased cAMP levels and PKA activity [reviewed in (Beaulieu and Gainetdinov, 2011) ]. Therefore, we investigated if elevation of intracellular cAMP levels in neurons is sufficient to result in enhanced perisynaptic BC cleavage. To do so, we used blue light-inducible AC encoded by AAV2/7.Syn-bPAC-2A-tdimer for optogenetic modulation of cAMP levels in the primary culture system as previously described (Stierl et al., 2011) . BC cleavage was analyzed around Homer 1-positive synapses at different time points after blue light illumination of the cells. Already 5 min after light stimulation we observed enhanced perisynaptic BC cleavage up to nearly 150 % ( Figure 7A ). This effect strength is comparable to our findings of pharmacologically induced perisynaptic BC cleavage, which was found 15 min after D1-like DA receptor activation. In the optogenetic approach, the rise in intracellular cAMP levels occurs much faster. As shown by (Stierl et al., 2011) , cAMP rises within about 1 second and is back to baseline about 1 min after light off in hippocampal neurons. The optogenetic cAMP elevation was sufficient to cause a brief increase in perisynaptic BC cleavage, since already 10 min after light stimulation the levels went back to baseline ( Figure 7A) , potentially due to highly active phosphodiesterases, which were not blocked in our experiments.
Figure 7: SKF81297-induced BC cleavage requires co-signaling through PKA and CaMKII
A) Elevated intracellular cAMP levels are crucial for an increase in BC cleavage around excitatory synapses (Ctl, 1 ± 0.0765, n = 5; 0 min, 0.9096 ± 0.1017, n = 7; 5 min, 1.42 ± 0.0481, n = 5; 10 min, 1.067 ± 0.0943, n = 6; 15 min, 1.042 ± 0.1552, n = 6; 30 min, 1.003 ± 0.1172, n = 6; 60 min, 0.8787 ± 0.0938, n = 6; 120 min, 0.6993 ± 0.1398, n = 4; 180 min, 0.7450 ± 0.1605, n = 4; average ± SEM; One-way ANOVA; P = 0.0207; Dunnett's Multiple Comparison Test; * P<0.05). B) Increased perisynaptic BC cleavage after D1-like DA receptor stimulation depends on PKA activation (Ctl, 1 ± 0.1044, n = 6; SKF, 1.468 ± 0.0805, n = 7; cAMPS-Rp, 0.8243 ± 0.1249, n = 8; cAMPs-Rp + SKF, 0.9714 ± 0.1567, n = 6; average ± SEM; One-way ANOVA; P = 0.0041; Dunnett's Multiple Comparison Test; ** P<0.01). C) SKF81297-induced perisynaptic BC cleavage is subjected to intracellular Ca 2+ signaling (Ctl, 1 ± 0.1139, n = 6; SKF, 1.648 ± 0.2978, n = 5; KN93, 0.9165 ± 0.1118, n = 4; SKF+KN93, 0.9303 ± 0.1126, n = 6; average ± SEM; One-way ANOVA; P = 0.0269; Dunnett's Multiple Comparison Test; * P<0.05). (nFI cl. BC = normalized fluorescent intensity of cleaved brevican)
DA-dependent BC cleavage requires co-signaling through PKA and CaMKII
Based upon this reductionistic approach to show involvement of cAMP, we further characterized the intracellular signaling cascade. Accordingly, we blocked PKA activity using the cell-permeable competitive antagonist cAMPS-Rp interacting with the cAMP binding sites on the regulatory subunits of PKA and analyzed again the perisynaptic amount of cleaved BC. PKA inhibition indeed abolished the SKF81297-induced increase in perisynaptic cleaved BC confirming the hypothesis that stimulation of D1-like DA receptors results in activation/release of the extracellular proteases in a PKA-dependent manner ( Figure 7B ). As D1R signaling was also reported to be alternatively mediated via protein kinase C (PKC) (Lee et al., 2004; Chen et al., 2007) we also tested for the involvement of this kinase utilizing bisindolylmaleimide II (1µM), however, no effect on DA-dependent perisynaptic BC cleavage was observed (data not shown).
As BC cleavage depends on signaling through NMDARs and L-type VGCC activation indicating increased Ca 2+ influx into the activated cells, we next tested the involvement of Ca 2+ /calmodulin-dependent kinase II (CaMKII) as a major downstream effector of Ca 2+ signaling. Blocking CaMKII using KN93 abolished the SKF81297-induced effect of increased perisynaptic BC cleavage ( Figure 7C ), suggesting that co-signaling via PKA and CaMKII is required to promote BC proteolysis (Figure 8 ).
Discussion
Here, we demonstrate that D1-like DA receptor stimulation leads to a restructuring of the ECM surrounding excitatory synapses of cortical neurons, as measured by increased BC and ACAN cleavage. This effect is mediated via the PKA-cAMP-pathway and requires network activity and NR2B/CaMKII activation, triggering extracellular proteases ADAMTS-4 and -5 ( Figure 8 ). Our findings show that the neuromodulator DA is a potential sculptor of the perisynaptic ECM, translating dopaminergic signals into structural plasticity of excitatory synapses. These findings pave the way to a deeper mechanistic understanding of the dopaminergic contribution to neuronal and synaptic plasticity via ECM remodeling.
Figure 8: Schematic illustration of the molecular mechanisms resulting in ECM remodeling after D1-like DA receptor activation
Activation of D1 DA receptors results in increased intracellular cAMP levels leading to downstream activation of PKA. Further, active PKA might be able to release already active proteases, such as ADAMTS-4 and ADAMTS-5 in the extracellular space to remodel the perisynaptic ECM (①). Besides its downstream signaling, stimulation of D1-like DA receptor can influence the Ca 2+ influx through NMDARs and L-type VGCC. Enhanced Ca 2+ influx activates CaMKII that might lead to the release of ADAMTS-4 and -5 into the extracellular space (②). D1-like DA receptor activation might result in a co-signaling of pathways ① and ②. All ADAMTS enzymes carry a prodomain to keep them in an inactive state. After D1-like DA receptor stimulation, PKA activation and enhanced Ca 2+ influx could result in the activation of pro-protein convertases (PPCs). Active PPCs themselves cleave off the pro-domain of ADAMTS-4 and -5 resulting in active enzymes ready for release (③). ADAMTS-4 and ADAMTS-5 are expressed also by astrocytes. Therefore, activation of neuronal or astrocytic D1-like DA receptors might cause a release of these enzymes by astrocytes as well (④).
How does DA contribute to local plasticity?
DA was shown to exert important neuromodulatory control over different forms of plasticity like LTP (Krug et al., 1983 ), long-term depression (LTD) (Calabresi et al., 1992) or STDP (Yang and Dani, 2014) [for summary see (Tritsch and Sabatini, 2012) ]. In neurons of the PFC, a key structure for abstract memory and decision making, DA was shown to act both as a tonic background regulator and as a phasically released modulator of LTP or LTD, in both paradigms following inverted U-functions (Otani et al., 2015) . The authors report LTP to be facilitated by tonic background DA levels, while LTD appeared to require acutely released DA for its facilitation.
Dopaminergic mechanisms were shown to be involved in spine restructuring. For instance, DA increase reverts aberrant structural plasticity in the NAc of alcohol-withdrawn rats by renormalizing the density of long thin spines and restoring limbic memory (Cannizzaro et al., 2019) . In a very elegant study, Yagishita et al. (2014) demonstrated that the DA-mediated support of spine enlargement upon stimulation has to occur within a narrow time window after NMDAR activation (Yagishita et al., 2014) . This mechanism of DA action involved D1Rs, PKA, NMDAR, and CaMKII, which is in good agreement with our findings presented here, thus pointing to the hypothesis that the DA-induced ECM remodelling observed by us may be involved in catecholaminergic spine morphology regulation. This is furthermore in In the PFC as well as in cortical cultures, D1Rs are considered the most prominent DA receptor subtypes, but D2Rs were also found in cortical areas [ (Gao and Wolf, 2007) ; reviewed in (Beaulieu and Gainetdinov, 2011) ] and in our in vitro culture system. However, D2R agonists had no effect on perisynaptic ECM proteolysis. Still, the possibility exists that D1R/D2R heterodimers are involved. Since there is evidence that these heteromers are preferentially coupled to Gα q G proteins, which activate PLC-IP3-DAG signaling [reviewed in (Tritsch and Sabatini, 2012) ] and we found PKC not involved in the D1R-agonist-induced ECM restructuring, it is rather unlikely that D1/D2 heteromers play a crucial role, although at this point we cannot completely rule out this possibility. Ito and colleagues (2007) identified the D1R-cAMP-PKA pathway as the underlying mechanism for enhanced extracellular tPA activity (Ito et al., 2007) . Based on our findings, Taken together, the signaling pathway identified in this study (Figure 8 ) could be of general significance for transducing DA signals into structural and functional consequences at synapses.
Induced ECM cleavage as a prerequisite for local structural and functional plasticity?
Restructuring or disintegration of the synaptic ECM has diverse effects on synaptic properties and characteristics, but most of the studies used exogenous glycosidase treatment rather than controlled endogenous proteolysis. Thus, glycosidic cleavage of ECM components proved to modulate synaptic short-term plasticity through exchange of postsynaptic glutamate receptors (Frischknecht et al., 2009 ). Further adding to this picture, synaptic LTP was also shown to be 
Does protease activation occur in a compartment-specific way?
Enzymes of the ADAMTS family are synthesized as pro-enzymes, which are cleaved at their (Tortorella et al., 2005) . Here, we demonstrated that furin or furin-like PPCs mediate DA-dependent perisynaptic BC cleavage, which is not happening at dendrites or inhibitory synapses, arguing for a locally restricted activation mechanism.
A recent study identified tPA as another potential activator for ADAMTS-4 in spinal cord injury leading to cleavage of inhibitory chondroitin sulfate proteoglycans (CSPGs) (Lemarchant et al., 2014) . Interestingly, tPA has been shown to display enhanced extracellular activity depending on the activation of postsynaptic D1Rs in the NAc (Ito et al., 2007) and it can also be considered a plausible candidate for local ADAMTS-4 activation in our study.
A critical view on the role of astrocytes
Astrocytes are additional players in dopaminergic signaling. Culture studies provided strong evidence that D1Rs and D5 receptors are expressed in rat astrocytes (Hösli and Hösli, 1986 Thus, remaining BC cleavage activity in our knockdown experiments may be due to residual enzymatic activity of astrocytic-derived ADAMTS-4. Noteworthy, astrocytes are a rich source of BC as well (Zhang et al., 2014) .
Loss of full-length lecticans vs. occurrence of fragments at synapses
Several functional consequences of the observed increase of cleaved lecticans at excitatory synapses are expected: limited disintegration of the perisynaptic ECM will support receptor mobility, volume transmission of neuromodulators, and structural changes in the synaptic architecture, as discussed above. Recent work suggests that BC controls AMPAR and K v 1 channel clustering on parvalbumin-positive interneurons (Favuzzi et al., 2017) , and our own preliminary data show a regulation of small-conductance Ca 2+ -activated K + (SK2) channels by BC in principal cells (Song et al., 2016) , raising the possibility that proteolytic degradation may thus locally change excitability and efficacy of synapses. At the same time, the lectican fragments may exert additional signaling functions. The new and emerging concept of matricryptins as biologically active ECM fragments containing a cryptic site normally not exposed in the intact molecule (Davis et al., 2000) , which was developed for non-neuronal tissues, may also apply to the neural ECM. This view is supported by the fact that the Nterminal BC fragment was shown to bind to HA and fibronectin, leading to enhanced cell adhesion in glioma (Hu et al., 2008) .
The decline in cleaved BC around synapses already 10 min after stimulation of intracellular cAMP levels ( Figure 7B , 1994) . This is in line with a more recent proteomic study showing massive upregulation of the hyaluronan and proteoglycan binding link protein 2 (HAPLN2) in the substantia nigra of these patients (Liu et al., 2015) .
BC and its cleavage fragments are not only important for healthy brain function but also in malignant glioma, the most common and deadly primary brain tumor (Held-Feindt et al.,
2006
). Up-regulation of BC and its predominantly ADAMTS-derived fragments has been shown to promote glioma invasion, while uncleavable BC was unable to enhance the invasive potential and tumor progression . Evidence for a link between BC proteolysis and synapses comes from the kainate model of epilepsy, where elevation in this ADAMTS-cleaved BC fragment was shown (Yuan et al., 2002) . They observed BC proteolysis in the dentate gyrus outer molecular layer is associated with diminished synaptic density, and thus it is plausible that it is involved in the kainate-induced synaptic loss and/or reorganization. Moreover, BC was shown to be implicated in drug addiction and craving. In heroin-addicted rats a clear decrease of full length BC in synaptic protein fractions of the PFC was noted (Van den Oever et al., 2010), and Lubbers et al. (2016) demonstrated that heterozygous BC mice expressing approx. 50% of the BC levels of wild-type mice, showed a progressive increase in cocaine-associated context preference over time, which may as well involve an interplay between ECM and dopaminergic modulation . Altogether, these findings highlight that fine-tuned and locally controlled proteolytic processing of mature ECM components may have important functional implications also for the diseased or addicted brain, potentially making it an interesting target for new treatment strategies. These findings highlight that fine-tuned and locally controlled proteolytic processing of mature ECM components has important functional implications for the brain.
